Role of insulin-like growth factor-I in regulating estrogen receptor-α gene expression

Journal of Cellular Biochemistry

Volumn 76, Issue 4, 2000, Pages 605-614

  Stoica, Adriana ^a   Saceda, Miguel ^a,b   Fakhro, Amina ^a   Joyner, Michael ^a   Martin, Mary Beth ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

ER IGF I effects; Gene expression

Indexed keywords

ESTROGEN RECEPTOR ALPHA; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; COS CELLS; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; INSULIN-LIKE GROWTH FACTOR I; POLYUNSATURATED ALKAMIDES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0033951059     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(20000315)76:4<605::AID-JCB9>3.0.CO;2-T     Document Type: Article

References (63)

1. Alemany J, Borras T, De Pablo F. 1990. Transcriptional stimulation of the delta-1 crystallin gene by IGF-I and insulin requires DNA cis elements in chicken. Proc Natl Acad Sci USA 87:3353-3357.
2. Alemany J, Klement JF, Borras T, De Pablo F. 1992. DNA binding factors which interact with the Sp1 site of the chicken delta-4-crystallin promoter are developmentally regulated. Biochem Biophys Res Commun 183:659-665.
3. Aronica SM, Katzenellenbogen B. 1993. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol Endocrinol 7:743-752.
4. Bunone G, Briand PA, Miksicek RJ, Picard D. 1996. Activation of the unliganded estrogen receptor by EGF involves the MAPK pathway and direct phosphorylation. EMBO J 15:2174-2183.
5. Chalbos D, Philips A, Galtier F, Rochefort H. 1993. Synthetic antiestrogens modulate induction of pS2 and cathepsin D mRNA by growth factors and AMP in MCF-7 cells. Endocrinology 133:571-576.
6. Chen C, Okayama H. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
7. Clayton SJ, May FEB, Westley BR. 1997. IGFs control the regulation of ER and PR expression by estrogens. Mol Cell Endocrinol 128:57-68.
8. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR. 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct pathways. J Biol Chem 272:12699-12702.
9. Culig Z. 1994. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54:5474-5478.
10. Cullen KJ, Lippman ME, Chow D, Hill S, Rosen N, Zwiebel JA. 1992. Insulin-like growth factor II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol Endocrinol 6:91-100.
11. Denner L, Ji HJ, Owen RD, Kato GJ, Clarke CL, Lee HY, Richardson PM, Pati UK. 1990. Steroid receptors, transcription factors, and gene expression. Cancer Res 50: 6430-6435.
12. Dufourny B, Alblas J, van Teeffelen H, van Schaik F, Van der Burg B, Steenbergh P, Sussenbach J. 1997. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J Biol Chem 272:31163-31171.
13. El-Tanani MKK, Green CD. 1997a. Two separate mechanisms for ligand-independent activation of the estrogen receptor. Mol Endocrinol 11:928-937.
14. El-Tanani MKK, Green CD. 1997b. Interaction between estradiol and growth factors in the regulation of specific gene expression in MCF-7 human breast cancer cells. J Steroid Biochem 60:269-276.
15. Fishman D, Galitzki L, Priai E, Segal S. 1997. EGF regulates protein kinase A activity in murine fibrosarcoma cells: differences between metastatic and nonmetastatic tumor cell variants. Cancer Res 57:5410-5415.
16. Garcia-Morales P, Saceda M, Kenney N, Kim N, Salomon DS, Gottardis MM, Solomon HB, Sholler PF, Jordan VC, Martin MB. 1994. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem 269:16896-16901.
17. Guvakova MA, Surmacz E. 1997a. Tamoxifen interferes with the IGF-I receptor signaling pathway in breast cancer cells. Cancer Res 57:2606-2610.
18. Guvakova MA, Surmacz E. 1997b. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp Cell Res 231:149-162.
19. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS. 1992. Coupling of dual signaling pathways: EGF action involves the ER. Proc Natl Acad Sci USA 89:4658-4662.
20. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA. 1993. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 7:992-998.
21. Ignar-Trowbridge DM, Pimentel MG, Parker MG, McLachlan JA, Korach KS. 1996. Peptide growth factors cross-talk with the estrogen receptor requires the A/B domain and occurs independent of protein kinase C or estradiol. Endocrinology 137:1735-1744.
22. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA. 1997. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89:166-170.
23. Jensen DE, Rich CB, Terpsta AJ, Farmer SR, Foster JA. 1995. Transcriptional regulation of the elastin gene by IGF-I involves disruption of Sp1 binding. J Biol Chem 270:6555-6563.
24. Jensen EV. 1996. Steroid hormones, receptors, and antagonists. Annu NY Acad Sci 784:1-16.
25. Johnson TM, Rosenberg MP, Meisler MH. 1993. An insulin-responsive element in the pancreatic enhancer of the amylase gene. J Biol Chem 268:464-468.
26. Jones PF, Jakubowitz T, Pitossi FJ, Maurer F, Hemmings BA. 1995. Molecular cloning and identification of a serine/ threonine protein kinase of the second-messenger subfamily. Nature 376:599-602.
27. Kaliman P, Canicio J, Shepherd PR, Beetson CA, Testrar X, Palacin M, Zorzano A. 1998. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Mol Endocrinol 12:66-77.
28. Kanda S, Hodgkin MN, Woodfield RJ, Wakelam MJO, Thomas G, Claesson-Welsh L. 1997. Phosphatidylinositol 3-kinase-independent p70 S6 kinase activation by flbroblast growth factor receptor-1 is important for proliferation but not for differentiation of endothelial cells. J Biol Chem 272:23347-23353.
29. Kastner P, Bocquel M, Turcotte B, Gamier JM, Horwitz KB, Chambon P, Gronemeyer H. 1990. Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms. J Biol Chem 265:12163-12167.
30. Katzenellenbogen BS, Norman MJ. 1990. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/ insulin-like growth factor-I, serum and estrogen. Endocrinology 126:891-898.
31. Lee AV, Weng CN, Jackson JG, Yee D. 1997. Activation of ER-mediated gene transcription by IGF-I inhuman breast cancer cells. J Endocrinol 152:39-47.
32. Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A. 1994. Insulin growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblasoma cell line SK-ER3. Mol Endocrinol 8:910-918.
33. Mani SK. 1996. Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. Mol Endocrinol 10:1728-1737.
34. Mani SK, Allen JM, Clark JH, Blaustein JD, O'Malley BW. 1994. Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior. Science 265:1246-1249.
35. Nazareth LV, Weigel NL. 1996. Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 271:19900-19907.
36. Newton CJ, Buric R, Trapp T, Brockmeier S, Pagotto U, Stalla GK 1994. The unliganded estrogen receptor transduces growth factor signals. J Steroid Biochem 48:481-486.
37. O'Brien RM, Lucas PC, Forest CD, Magnuson MA, Grannen DK. 1990. Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription. Science 249:533-537.
38. Pakdel F, Reese JC, Katzenellenbogen BS. 1993. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor. Mol Endocrinol 7:1408-1417.
39. Petley T, Graff K, Jiang W, Yang H, Florini J. 1999. Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm Metab Res 31:70-76.
40. Philippe J. 1991. Insulin regulation of the glucagon gene is mediated by an insulin responsive DNA element. Proc Natl Acad Sci USA 88:7224-7227.
41. Pietras RJ, Arboleda J, Reese DM, Wongripat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwhowski MX, Slamon DJ. 1995. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10:2435-2446.
42. Rocha RL, Hilsenbeck SG, Jackson JG, Yee D. 1995. Insulin-like growth factor binding protein-3 (IGFBP-3) and insulin receptor substrate 1 (IRS1) in primary breast cancer: larger tumors have higher IGFBP-3 levels and high levels of IRS-1 are associated with lower disease-free survival rate (DFS) rate. Breast Cancer Res Treat 137(suppl):55.
43. Saceda M, Lippman ME, Chambon P, Lindsey RK, Puente M, Martin MB. 1988. Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 2:1157-1162.
44. Sahlin L, Nostedt G, Eriksson H. 1994. Estrogen regulation of the estrogen receptor and IGF-I in the rat uterus: a potential coupling between effects of estrogen and IGF-I. Steroids 59:421-430.
45. Stancel GM, Gardner RM, Kirland JL, Liu TH, Lingham RB, Loose-Mitchell DS, Mukku VR, Orengo CA, Verner G. 1987. Interactions between estrogen and EGF in uterine growth. Adv Exp Med Biol 230:99-118.
46. Stewart AJ, Johnson MD, May FEB, Westley BR. 1990. Role of insulin-like growth factors and the type I IGF receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 178:21172-21178.
47. Stoica A, Saceda M, Fakhro A, Solomon HB, Fenster BD, Martin MB. 1997. The role of transforming growth factor-B in regulation of estrogen receptor expression in the MCF-7 breast cancer cell line. Endocrinology 138:1498-1505.
48. Surmacz E, Burgand JL. 1995. Overexpression of insulin receptor substrate-1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirement for growth and transformation. Clin Cancer Res 1:1429-1436.
49. Suwanickul A, Morris SL, Powell DR. 1993. Identification of an insulin-responsive element in the promoter of the human gene for insulin-like growth factor binding protein-1. J Biol Chem 268:17063-17068.
50. Takahashi Y, Toke K, Kadowaki H, Katsumata D, Fukushima Y, Yazaki Y, Akanuma Y, Kadowaki T. 1997. Role of insulin receptor substrate-1 and shc on insulin-like growth factor receptor signaling in early passage of cultured human fibroblasts. Endocrinology 138:741-750.
51. Teruel T, Valverde AM, Benito M, Lorenzo M. 1996. Insulin-like growth factor I and insulin induce adipogenic-related gene expression in foetal brown adipocyte primary cultures. J Biol Chem 319:627-632.
52. Tsai MJ, O'Malley BW. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486.
53. Umayahava Y, Kawamori R, Watada H, Imano E, Iwana N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T. 1994. Estrogen regulation of the IGF-I gene transcription involves an AP-1 enhancer. J Biol Chem 269:16433-16442.
54. Urban RJ, Shupnic MA, Bodenhog JH. 1994. IGF-I increase expression of the porcine P-450 cholesterol side chain cleavage gene through a GC-rich domain. J Biol Chem 269:25761-25769.
55. Urban RJ, Bodenhog YH. 1996. Transcriptional activation of the porcine P-450 11AIGF response element in MCF-7 breast cancer cells. J Biol Chem 271:31695-31698.
56. Valverde AM, Lorenzo M, Navarro P, Benito M. 1997. Phosphatidylinositol 3-kinase is a requirement for insulin-like growth factor I-induced differentiation, but not for mitogenesis, in fetal brown adipocytes. Mol Endocrinol 11:595-607.
57. Vlahos CJ, Matter WF, Kui KY, Brown RF. 1994. A specific inhibitor of phosphatidylinositoi 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248.
58. Weigel NL. 1996. Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319:657-667.
59. Westley BR, May FEB. 1994. Role of insulin-like growth factors in steroid-modulated proliferation. J Steroid Biochem 51:1-9.
60. Winston R, Kao PC, Kiang DT. 1994. Regulation of insulin-like growth factors by antiestrogen. Breast Cancer Res Treat 31:107-115.
61. Wolfe BL, Rich CB, Goud HD, Terstra AJ, Bashir M, Rosenbloom J, Sonenshein GE, Foster JA. 1993. IGF-I regulates transcription of the elastin gene. J Biol Chem 268: 12418-12426.
62. Yee D. 1994. The insulin-like growth factor system as a target in breast cancer. Breast Cancer Res Treat 32:85-95.
63. Zhang Y, Bai W, Allgood VE, Weigel NL. 1994. Multiple signaling pathways activate the chicken progesterone receptor. Mol Endocrinol 8:577-584.